Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage

American Journal of Pathology

Volumn 176, Issue 4, 2010, Pages 1648-1659

  Castellano, Giuseppe ^a   Melchiorre, Rita ^a   Loverre, Antonia ^a   Ditonno, Pasquale ^a   Montinaro, Vincenzo ^a   Rossini, Michele ^a   Divella, Chiara ^a   Battaglia, Michele ^a   Lucarelli, Giuseppe ^a   Annunziata, Gennaro ^a   Palazzo, Silvano ^a   Selvaggi, Francesco Paolo ^a   Staffieri, Francesco ^a   Crovace, Antonio ^a   Daha, Mohamed R ^b   Mannesse, Maurice ^c   Van Wetering, Sandra ^c   Schena, Francesco Paolo ^a   Grandaliano, Giuseppe ^a  

^a UNIVERSITY OF BARI   (Italy)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Pharming Group NV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; CD163 ANTIGEN; CD4 ANTIGEN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C4D; COMPLEMENT COMPONENT C5B; CYCLOSPORIN A; LECTIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CLINICAL ARTICLE; COMPLEMENT CLASSICAL PATHWAY; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; DRUG DOSE REDUCTION; FEMALE; GLOMERULUS CAPILLARY; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE; NONHUMAN; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; RENAL PROTECTION; REPERFUSION INJURY; SWINE;

EID: 77950576323     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090276     Document Type: Article

References (43)

1. Perico N, Cattaneo D, Sayegh MH, Remuzzi G: Delayed graft function in kidney transplantation. Lancet 2004, 364: 1814-1827 (Pubitemid 39488068)
2. Gueler F, Gwinner W, Schwarz A, Haller H: Long-term effects of acute ischemia and reperfusion injury. Kidney Int 2004, 66: 523-527 (Pubitemid 38981991)
3. Peeters P, Vanholder R: Therapeutic interventions favorably influencing delayed and slow graft function in kidney transplantation: mission impossible? Transplantation 2008, 85: S31-S37
4. Sacks SH, Chowdhury P, Zhou W: Role of the complement system in rejection. Curr Opin Immunol 2003, 15: 487-492
5. Li K, Sacks SH, Zhou W: The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies. Mol Immunol 2007, 44: 3866-3874 (Pubitemid 47332623)
6. Ricklin D, Lambris JD: Complement-targeted therapeutics. Nature Biotechnol 2007, 25: 1265-1275
7. Walport MJ: Complement. First of two parts. N Engl J Med 2001, 344: 1058-1066
8. Zhou W, Farrar CA, Abe K, Pratt JR, Marsh JE, Wang Y, Stahl GL, Sacks SH: Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 2000, 105: 1363-1371 (Pubitemid 30322402)
9. Thurman JM, Royer PA, Ljubanovic D, Dursun B, Lenderink AM, Edelstein CL, Holers VM: Treatment with an inhibitory monoclonal antibody to mouse factor B protects mice from induction of apoptosis and renal ischemia/reperfusion injury. J Am Soc Nephrol 2006, 17: 707-715
10. Arumugam TV, Shiels IA, Strachan AJ, Abbenante G, Fairlie DP, Taylor SM: A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats. Kidney Int 2003, 63: 134-142 (Pubitemid 35463914)
11. Mollnes TE, Kirschfink M: Strategies of therapeutic complement inhibition. Mol Immunol 2006, 43: 107-121
12. Thorgersen EB, Ghebremariam YT, Thurman JM, Fung M, Nielsen EW, Holers VM, Kotwal GJ, Mollnes TE: Candidate inhibitors of porcine complement. Mol Immunol 2007, 44: 1827-1834
13. Davis AE, III, Mejia P, Lu F: Biological activities of C1 inhibitor. Mol Immunol 2008, 45: 4057-4063
14. Thurman JM: Triggers of inflammation after renal ischemia/reperfusion. Clin Immunol 2007, 123: 7-13
15. Seelen MA, Roos A, Wieslander J, Mollnes TE, Sjoholm AG, Wurzner R, Loos M, Tedesco F, Sim RB, Garred P, Alexopoulos E, Turner MW, Daha MR: Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Methods 2005, 296: 187-198 (Pubitemid 40174752)
16. Loverre A, Capobianco C, Stallone G, Infante B, Schena A, Ditonno P, Palazzo S, Battaglia M, Crovace A, Castellano G, Ranieri E, Schena FP, Gesualdo L, Grandaliano G: Ischemia-reperfusion injury-induced abnormal dendritic cell traffic in the transplanted kidney with delayed graft function. Kidney Int 2007, 72: 994-1003 (Pubitemid 47530577)
17. Chatterjee PK: Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review. Naunyn Schmiedebergs Arch Pharmacol 2007, 376: 1-43
18. Zhang M, Alicot EM, Chiu I, Li J, Verna N, Vorup-Jensen T, Kessler B, Shimaoka M, Chan R, Friend D, Mahmood U, Weissleder R, Moore FD, Carroll MC: Identification of the target self-antigens in reperfusion injury. J Exp Med 2006, 203: 141-152 (Pubitemid 43139653)
19. Zhang M, Takahashi K, Alicot EM, Vorup-Jensen T, Kessler B, Thiel S, Jensenius JC, Ezekowitz RA, Moore FD, Carroll MC: Activation of the lectin pathway by natural IgM in a model of ischemia/reperfusion injury. J Immunol 2006, 177: 4727-4734 (Pubitemid 44469806)
20. Park P, Haas M, Cunningham PN, Bao L, Alexander JJ, Quigg RJ: Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes. Am J Physiol Renal Physiol 2002, 282: F352-F357 (Pubitemid 34654567)
21. Thurman JM, Ljubanovic D, Edelstein CL, Gilkeson GS, Holers VM: Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice. J Immunol 2003, 170: 1517-1523 (Pubitemid 36139523)
22. Collard CD, Montalto MC, Reenstra WR, Buras JA, Stahl GL: Endothelial oxidative stress activates the lectin complement pathway: role of cytokeratin 1. Am J Pathol 2001, 159: 1045-1054
23. Berger SP, Roos A, Mallat MJ, Fujita T, De Fijter JW, Daha MR: Association between mannose-binding lectin levels and graft survival in kidney transplantation. Am J Transplant 2005, 5: 1361-1366 (Pubitemid 40839426)
24. Nickeleit V, Zeiler M, Gudat F, Thiel G, Mihatsch MJ: Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol 2002, 13: 242-251 (Pubitemid 34042034)
25. van Doorn MB, Burggraaf J, van Dam T, Eerenberg A, Levi M, Hack CE, Schoemaker RC, Cohen AF, Nuijens J: A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema. J Allergy Clin Immunol 2005, 116: 876-883 (Pubitemid 41400555)
26. Choi G, Soeters MR, Farkas H, Varga L, Obtulowicz K, Bilo B, Porebski G, Hack CE, Verdonk R, Nuijens J, Levi M: Recombinant human C1-inhibitor in the treatment of acute angioedema attacks. Transfusion 2007, 47: 1028-1032 (Pubitemid 46802091)
27. De Simoni MG, Storini C, Barba M, Catapano L, Arabia AM, Rossi E, Bergamaschini L: Neuroprotection by complement (C1) inhibitor in mouse transient brain ischemia. J Cereb Blood Flow Metab 2003, 23: 232-239
28. De Simoni MG, Rossi E, Storini C, Pizzimenti S, Echart C, Bergamaschini L: The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q. Am J Pathol 2004, 164: 1857-1863 (Pubitemid 38529788)
29. Storini C, Rossi E, Marrella V, Distaso M, Veerhuis R, Vergani C, Bergamaschini L, De Simoni MG: C1-inhibitor protects against brain ischemia-reperfusion injury via inhibition of cell recruitment and inflammation. Neurobiol Dis 2005, 19: 10-17 (Pubitemid 40544719)
30. de Zwaan C, Kleine AH, Diris JH, Glatz JF, Wellens HJ, Strengers PF, Tissing M, Hack CE, Dieijen-Visser MP, Hermens WT: Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarction. Eur Heart J 2002, 23: 1670-1677 (Pubitemid 36287778)
31. Heijnen BH, Straatsburg IH, Padilla ND, Van Mierlo GJ, Hack CE, Van Gulik TM: Inhibition of classical complement activation attenuates liver ischaemia and reperfusion injury in a rat model. Clin Exp Immunol 2006, 143: 15-23
32. Inderbitzin D, Beldi G, Avital I, Vinci G, Candinas D: Local and remote ischemia-reperfusion injury is mitigated in mice overexpressing human C1 inhibitor. Eur Surg Res 2004, 36: 142-147 (Pubitemid 38621568)
33. Bergamaschini L, Gobbo G, Gatti S, Caccamo L, Prato P, Maggioni M, Braidotti P, Di Stefano R, Fassati LR: Endothelial targeting with C1-inhibitor reduces complement activation in vitro and during ex vivo reperfusion of pig liver. Clin Exp Immunol 2001, 126: 412-420 (Pubitemid 34008711)
34. Sozzani S, Sallusto F, Luini W, Zhou D, Piemonti L, Allavena P, Van Damme J, Valitutti S, Lanzavecchia A, Mantovani A: Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J Immunol 1995, 155: 3292-3295
35. Nauta AJ, Daha MR, Tijsma O, van de WB, Tedesco F, Roos A: The membrane attack complex of complement induces caspase activation and apoptosis. Eur J Immunol 2002, 32: 783-792 (Pubitemid 34257556)
36. Pippin JW, Durvasula R, Petermann A, Hiromura K, Couser WG, Shankland SJ: DNA damage is a novel response to sublytic complement C5b-9-induced injury in podocytes. J Clin Invest 2003, 111: 877-885 (Pubitemid 37074963)
37. Nangaku M, Pippin J, Couser WG: Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome. J Am Soc Nephrol 1999, 10: 2323-2331 (Pubitemid 29501465)
38. Hughes J, Nangaku M, Alpers CE, Shankland SJ, Couser WG, Johnson RJ: C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis. Am J Physiol Renal Physiol 2000, 278: F747-F757 (Pubitemid 30351076)
39. Feucht HE, Schneeberger H, Hillebrand G, Burkhardt K, Weiss M, Riethmuller G, Land W, Albert E: Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993, 43: 1333-1338 (Pubitemid 23161421)
40. de Vries B, Walter SJ, Peutz-Kootstra CJ, Wolfs TG, van Heurn LW, Buurman WA: The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury. Am J Pathol 2004, 165: 1677-1688
41. Haas M, Ratner LE, Montgomery RA: C4d staining of perioperative renal transplant biopsies. Transplantation 2002, 74: 711-717
42. Sund S, Hovig T, Reisaeter AV, Scott H, Bentdal O, Mollnes TE: Complement activation in early protocol kidney graft biopsies after living-donor transplantation. Transplantation 2003, 75: 1204-1213 (Pubitemid 36513022)
43. Imai N, Nishi S, Alchi B, Ueno M, Fukase S, Arakawa M, Saito K, Takahashi K, Gejyo F: Immunohistochemical evidence of activated lectin pathway in kidney allografts with peritubular capillary C4d deposition. Nephrol Dial Transplant 2006, 21: 2589-2595 (Pubitemid 44644536)